Combination pairs leading brands: Remedy Meds, Keeps, Nurx, and Cove, with a nationwide clinician and pharmacy network to expand access to high-demand, digitally scalable treatments.
Remedy Meds, LLC, a consumer virtual-care and pharmacy platform, today announced it has entered into a definitive agreement to acquire Thirty Madison, Inc. (“Thirty Madison”). The transaction creates a larger, multi-brand platform across women’s, men’s, and metabolic health.
The transaction, which is valued just north of $500M, will be funded through an all-stock deal. Closing is expected in Q4 2025, subject to customary closing conditions and regulatory review.
Strategic Rationale
- Scaled, multi-brand platform. Combines Remedy Meds (weight loss), Keeps (men’s hair loss), Nurx (women’s health), and Cove (migraine) under one consumer-centric platform with cross-category trust and funnel efficiency.
- Integrated care & pharmacy. Nationwide clinician coverage, insurance coverage, and an integrated pharmacy fulfillment network support same-day video visits, rapid prescription review, tailored treatment plans, and direct-to-door delivery.
- Robust financial performance. Remedy Meds today sits at $450M+ in annual revenue with substantial profitability, allowing Thirty Madison’s profitable, $220M+ revenue business to benefit from the financials of a scaled operating platform.
Executive Quotes
“By bringing together Thirty Madison’s trusted brands with Remedy Med’s acquisition engine, retention system, and pharmacy infrastructure, we will broaden access, shorten time-to-treatment, and maintain the financial discipline that has defined our growth,” said Haris Memon, Founder and CEO of Remedy Meds.
“Thirty Madison and Remedy Meds share a belief that patients deserve a better healthcare experience. Together we will deliver on making high-quality specialty care easier to access for millions of patients across the conditions we serve. I’m grateful to our teammates, clinicians, and partners who made this possible — and incredibly excited for what we’ll build together in this next stage of growth as a part of Remedy Meds,” said Demetri Karagas, CEO and Co-Founder of Thirty Madison.
